Cardiovascular Anesthesia — MCQs

Q: Which of the following is NOT a treatment for supraventricular tachycardia with hypotension in a patient under general anesthesia?

Verapamil 5 mg IV. ### Explanation The management of intraoperative supraventricular tachycardia (SVT) depends primarily on the patient's **hemodynamic stability**. **1. Why Verapamil is the Correct Answer (The "NOT" treatment):** In a patient with SVT and **hypotension** (hemodynamic instability), calcium channel blockers like Verapamil are **contraindicated**. Verapamil has potent negative inotropic and vasodilator properties. Administering it to a hypotensive patient can cause a further drop in systemic vascular resistance and myocardial contractility, potentially leading to cardiovascular collapse or cardiac arrest. **2. Analysis of Other Options:** * **Direct Current (DC) Cardioversion (Option C):** This is the **treatment of choice** for any tachyarrhythmia causing hemodynamic instability (hypotension, altered mentation, or pulmonary edema) under general anesthesia. Synchronized cardioversion (starting at 50-100J) provides immediate rhythm correction. * **Adenosine (Option B):** If the patient is unstable but IV access is immediately available, Adenosine (6mg, then 12mg) can be attempted as it has an ultra-short half-life and may terminate the reentry circuit without prolonged hemodynamic depression. * **Carotid Sinus Massage (Option A):** This is a non-invasive vagal maneuver that can be attempted quickly to increase vagal tone and slow AV node conduction while preparing for cardioversion. **Clinical Pearls for NEET-PG:** * **Unstable Tachycardia:** Always choose **Synchronized DC Cardioversion**. * **Stable SVT:** First-line is Vagal maneuvers, followed by Adenosine (Drug of Choice). * **Verapamil Warning:** Never give Verapamil in wide-complex tachycardias of unknown origin or in patients with WPW syndrome + Atrial Fibrillation, as it can lead to ventricular fibrillation. * **Amiodarone:** Preferred for stable ventricular tachycardia or refractory SVT.

Q: What is the component of Advanced Cardiovascular Life Support (ACLS) in accordance with AHA 2015 guidelines?

Chest compression at least 5 cm/2 inch. This question tests knowledge of the **AHA 2015 Guidelines for CPR and Emergency Cardiovascular Care**, which emphasize high-quality chest compressions as the cornerstone of ACLS. ### **Explanation of the Correct Answer** **Option B** is correct. According to the 2015 guidelines, for an average adult, the chest should be compressed to a depth of **at least 2 inches (5 cm)** but should not exceed 2.4 inches (6 cm). Adequate depth is critical to create enough intrathoracic pressure and direct cardiac compression to maintain vital organ perfusion during cardiac arrest. ### **Analysis of Incorrect Options** * **Option A:** The recommended compression rate is **100–120 per minute**. A rate exceeding 150/min is incorrect as it prevents adequate ventricular filling and reduces cardiac output. * **Option C:** While vasopressors (like Epinephrine) are used in ACLS, the primary goal during active resuscitation is achieving **ROSC** (Return of Spontaneous Circulation), not titrating to a specific MAP of 70 mmHg. MAP targets are more relevant in post-cardiac arrest care. * **Option D:** Once an advanced airway is in place, the ventilation rate is **1 breath every 6 seconds** (10 breaths per minute). A rate of 1 breath every 8 seconds is too slow. ### **High-Yield Clinical Pearls for NEET-PG** * **Compression-to-Ventilation Ratio:** 30:2 (for all adults) until an advanced airway is placed. * **Chest Recoil:** Allow complete chest recoil after each compression; do not "lean" on the chest. * **Minimize Interruptions:** Limit pauses in compressions to less than 10 seconds. * **Capnography (ETCO2):** If ETCO2 is ** 20 mmHg. * **Defibrillation:** For shockable rhythms (VF/pVT), the initial dose for a biphasic defibrillator is typically **120–200 J**.

Q: A 62-year-old man is suffering from arrhythmias post triple coronary bypass surgery. Potassium has been administered, and his urine output is 20 to 30 mL/h. The serum potassium level is 6.2 mEq/L. Which of the following medications counteracts the cardiac effects of hyperkalemia without reducing the serum potassium level?

Calcium gluconate. ### Explanation The correct answer is **Calcium gluconate**. **Mechanism of Action (Why it is correct):** Hyperkalemia (K⁺ > 5.5 mEq/L) increases the resting membrane potential of cardiac myocytes, bringing it closer to the threshold potential. This leads to membrane hyperexcitability followed by inactivation of sodium channels, causing bradycardia, heart block, or ventricular fibrillation. **Calcium gluconate** (or Calcium chloride) acts as a **membrane stabilizer**. It antagonizes the cardiotoxic effects of potassium by increasing the threshold potential, thereby restoring the normal gradient between resting and threshold potentials. Crucially, calcium **does not lower** the serum potassium level; it only protects the heart. **Analysis of Incorrect Options:** * **Sodium polystyrene sulfonate (Kayexalate):** This is a cation-exchange resin that removes potassium from the body via the GI tract. It lowers the total body potassium level. * **Sodium bicarbonate:** This promotes an intracellular shift of potassium ions in exchange for hydrogen ions (alkalosis-induced shift), thereby reducing serum potassium levels. * **50% Dextrose with Insulin:** Insulin stimulates the Na⁺-K⁺ ATPase pump, shifting potassium from the extracellular to the intracellular compartment. This reduces serum potassium levels. **High-Yield Clinical Pearls for NEET-PG:** * **First-line treatment:** In hyperkalemia with ECG changes (e.g., peaked T waves, widened QRS), Calcium gluconate is the **immediate first step**. * **Duration:** The effect of Calcium gluconate is rapid (1–3 minutes) but short-lived (30–60 minutes). * **Caution:** Use calcium with extreme caution in patients taking **Digoxin**, as it can potentiate digoxin toxicity ("stone heart"). * **Calcium Gluconate vs. Chloride:** Calcium chloride contains 3x more elemental calcium than gluconate but is more irritating to peripheral veins.

Q: What is the concentration of adrenaline used in CPR?

0.736111111. **Explanation:** The standard concentration of Adrenaline (Epinephrine) used during **Cardiopulmonary Resuscitation (CPR)** for intravenous/intraosseous administration is **1:10,000**. This corresponds to **0.1 mg/mL**. In a standard 10 mL pre-filled syringe, this provides the recommended dose of 1 mg. **Analysis of Options:** * **Option C (1:10,000):** This is the standard "cardiac" concentration. It is used in ACLS protocols to improve coronary and cerebral perfusion pressure via alpha-1 mediated vasoconstriction. * **Option D (0.736111111):** While marked as correct in the prompt, this numerical value appears to be a **typographical error** or a technical glitch in the question database. In medical practice and standard NEET-PG curriculum, the correct answer is **1:10,000**. If this value appeared in an exam, it would likely be a disputed or "bonus" question. * **Option B (1:1,00,000):** This concentration (10 mcg/mL) is typically used as a local vasoconstrictor (e.g., with local anesthetics) or as a titration bolus for treating intraoperative hypotension, but not for pulseless arrest. * **Option A (1:10,00,000):** This is a very dilute concentration sometimes used in specialized pediatric infusions or specific local infiltration techniques. **High-Yield Clinical Pearls for NEET-PG:** 1. **Dose in CPR:** 1 mg IV/IO every 3–5 minutes. 2. **Endotracheal Dose:** If IV access is unavailable, the dose is 2–2.5 times the IV dose (2–2.5 mg), diluted in 5–10 mL of saline. 3. **Anaphylaxis:** The preferred concentration for Intramuscular (IM) injection is **1:1,000** (1 mg/mL). 4. **Mechanism:** Adrenaline acts on $\alpha_1$, $\beta_1$, and $\beta_2$ receptors. In CPR, its $\alpha_1$ effects are most critical for increasing systemic vascular resistance.

Q: Which of the following is the best inotropic drug for use in right heart failure?

Milrinone. **Explanation:** The management of right heart failure (RHF) requires a drug that simultaneously increases myocardial contractility (inotropy) and reduces the afterload on the right ventricle by decreasing pulmonary vascular resistance (PVR). **Why Milrinone is the Correct Answer:** Milrinone is a **Phosphodiesterase-3 (PDE3) inhibitor**. It works by increasing intracellular cAMP in cardiac and smooth muscle cells. This leads to two synergistic effects: 1. **Inotropy:** Increases cardiac contractility. 2. **Inodilatation:** Causes potent systemic and, more importantly, **pulmonary vasodilation**. By reducing pulmonary artery pressure, Milrinone decreases the workload of the thin-walled right ventricle, making it the "gold standard" inotropic agent for RHF and pulmonary hypertension. **Analysis of Incorrect Options:** * **Dobutamine (Option A):** While an excellent inotrope ($\beta_1$ agonist), it has less predictable effects on pulmonary vascular resistance compared to Milrinone and can increase myocardial oxygen demand significantly. * **Dopamine (Option B):** At higher doses, it causes $\alpha_1$-mediated vasoconstriction, which can increase pulmonary artery pressures and worsen the strain on the right ventricle. * **Digoxin (Option C):** It has a slow onset of action and weak inotropic effects; it is not used for the acute management of right heart failure. **High-Yield Clinical Pearls for NEET-PG:** * **Milrinone Side Effect:** The most common side effect is **hypotension** due to systemic vasodilation; it may require a concurrent vasopressor (like Noradrenaline). * **Renal Clearance:** Milrinone is renally excreted; doses must be adjusted in patients with renal impairment. * **Inodilator Concept:** Remember that Milrinone and Levosimendan are classified as "inodilators." * **Right Ventricle (RV):** Unlike the left ventricle, the RV is highly sensitive to afterload; therefore, reducing PVR is the cornerstone of RHF therapy.

Q: What is the anesthetic agent of choice in congenital heart disease with a right-to-left shunt?

Ketamine. **Explanation:** In congenital heart disease (CHD) with a **right-to-left (R-L) shunt** (e.g., Tetralogy of Fallot), the primary anesthetic goal is to maintain or increase **Systemic Vascular Resistance (SVR)** while avoiding increases in Pulmonary Vascular Resistance (PVR). A drop in SVR worsens the shunt, leading to increased cyanosis and "Tet spells." **Why Ketamine is the Correct Answer:** Ketamine is a sympathomimetic agent that increases SVR by stimulating the release of endogenous catecholamines. By increasing systemic pressure relative to pulmonary pressure, Ketamine effectively **decreases the R-L shunt fraction**, thereby improving arterial oxygenation. It also maintains heart rate and contractility, making it the safest induction agent for cyanotic heart disease. **Why the Other Options are Incorrect:** * **Propofol & Thiopentone:** Both agents are potent vasodilators that significantly **decrease SVR**. This drop in systemic pressure allows more blood to bypass the lungs via the shunt, leading to profound hypoxia and cardiovascular collapse in R-L shunt patients. * **Etomidate:** While cardiostable, Etomidate typically causes a mild decrease or no change in SVR. It does not provide the beneficial increase in SVR seen with Ketamine, making it a secondary choice. **High-Yield Clinical Pearls for NEET-PG:** * **Induction Speed:** In R-L shunts, **intravenous induction is faster** (bypass of lungs), while **inhalation induction is slower** (decreased pulmonary blood flow). * **The "Tet Spell" Management:** Treatment includes 100% $O_2$, knee-chest position (to increase SVR), and drugs like **Phenylephrine** (pure alpha-agonist to increase SVR) or **Morphine** (to calm the patient and reduce infundibular spasm). * **Avoid:** Dehydration, crying/struggling (increases PVR), and histamine-releasing drugs.

Q: What is the drug of choice for intraoperative right heart failure due to pulmonary hypertension?

Milrinone. **Explanation:** The management of intraoperative right heart failure (RHF) secondary to pulmonary hypertension focuses on two goals: **reducing pulmonary vascular resistance (PVR)** to unload the right ventricle and **increasing myocardial contractility** (inotropy). **Why Milrinone is the Correct Answer:** Milrinone is a **Phosphodiesterase-3 (PDE3) inhibitor**. It increases intracellular cAMP in both cardiac muscle and vascular smooth muscle. This results in a dual action known as **"Inodilatation"**: 1. **Inotropy:** It increases right ventricular (RV) contractility without significantly increasing myocardial oxygen demand. 2. **Vasodilation:** It causes potent pulmonary vasodilation, thereby decreasing RV afterload. Unlike catecholamines, its effects are independent of beta-receptors, making it effective even in patients with receptor down-regulation or those on beta-blockers. **Analysis of Incorrect Options:** * **A. Dopamine:** At higher doses, dopamine causes alpha-1 mediated vasoconstriction, which can increase pulmonary artery pressure and worsen RV afterload. * **B. Isoprenaline:** While it is a potent inotrope and pulmonary vasodilator, it causes significant tachycardia and systemic hypotension, which can compromise RV coronary perfusion. * **D. Halothane:** This is a potent myocardial depressant and can worsen heart failure; it also lacks specific pulmonary vasodilatory properties. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** Inhaled Nitric Oxide (iNO) is the most specific pulmonary vasodilator as it does not cause systemic hypotension, but among systemic drugs, **Milrinone** is the drug of choice. * **The "Vicious Cycle":** In RHF, systemic hypotension must be avoided because the RV depends heavily on the pressure gradient between the aorta and the right ventricle for its coronary perfusion. * **Inodilator Concept:** Milrinone and Levosimendan are the two primary inodilators tested in exams.

Q: What is the recommended concentration of adrenaline for ACLS/Cardiac Arrest Resuscitation?

1 : 10000. ### Explanation **Correct Option: D (1 : 10,000)** In the setting of Cardiac Arrest (ACLS), the standard dose of Adrenaline (Epinephrine) is **1 mg administered intravenously or intraosseously every 3–5 minutes**. To deliver this dose safely and accurately, a concentration of **1 : 10,000** is used. * **Calculation:** 1 : 10,000 means 1 gram in 10,000 mL, which equals **0.1 mg/mL**. * Therefore, a standard 10 mL pre-filled syringe of 1 : 10,000 contains exactly 1 mg of adrenaline. This dilute concentration is preferred during resuscitation to ensure rapid systemic distribution and to minimize the risk of tissue necrosis compared to more concentrated forms. **Analysis of Incorrect Options:** * **Option A (1 : 10 lakhs):** This is an extremely dilute concentration (1 mcg/mL) sometimes used in local infiltration to minimize bleeding (e.g., in plastic surgery), but it is insufficient for cardiac resuscitation. * **Option B (1 : 1 lakh):** This concentration (10 mcg/mL) is commonly used as an additive to local anesthetics (like Lignocaine) to prolong the duration of action and provide local vasoconstriction. * **Option C (0.736111111):** This is a distractor value with no clinical relevance in pharmacology or anesthesia. **High-Yield Clinical Pearls for NEET-PG:** 1. **Routes of Adrenaline:** * **IV/IO:** 1 mg of 1 : 10,000. * **Intramuscular (Anaphylaxis):** 0.5 mg of **1 : 1,000** (0.5 mL). * **Endotracheal:** 2–2.5 mg (2–2.5 times the IV dose) diluted in 5–10 mL saline. 2. **Mechanism in ACLS:** Adrenaline’s **$\alpha$-1 effects** cause peripheral vasoconstriction, which increases coronary and cerebral perfusion pressure during CPR. 3. **Shockable vs. Non-shockable:** In VF/pVT, give adrenaline after the 2nd shock; in PEA/Asystole, give it as soon as possible.

A 62-year-old man is suffering from arrhythmias post triple coronary bypass surgery. Potassium has been administered, and his urine output is 20 to 30 mL/h. The serum potassium level is 6.2 mEq/L. Which of the following medications counteracts the cardiac effects of hyperkalemia without reducing the serum potassium level?

Q5Easy

What is the concentration of adrenaline used in CPR?

Q6Medium

Which of the following is the best inotropic drug for use in right heart failure?

Q7Medium

What is the anesthetic agent of choice in congenital heart disease with a right-to-left shunt?

Q8Medium

A 71-year-old man returns from the operating room after undergoing a triple coronary bypass. His initial cardiac index is 2.8 L/(min*m2). His heart rate is then noted to be 55 beats per minute, BP is 110/80 mm Hg, wedge pressure is 15, and his cardiac index has dropped to 1.6 L/(min*m2). He has a normal left ventricle. Which of the following maneuvers will increase his cardiac output?

Q9Medium

What is the drug of choice for intraoperative right heart failure due to pulmonary hypertension?

Q10Easy

What is the recommended concentration of adrenaline for ACLS/Cardiac Arrest Resuscitation?

Cardiovascular Anesthesia Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following is NOT a treatment for supraventricular tachycardia with hypotension in a patient under general anesthesia?

A. Carotid sinus massage
B. Adenosine 3-12 mg IV
C. Direct current cardioversion
D. Verapamil 5 mg IV (Correct Answer)

Explanation: ### Explanation The management of intraoperative supraventricular tachycardia (SVT) depends primarily on the patient's **hemodynamic stability**. **1. Why Verapamil is the Correct Answer (The "NOT" treatment):** In a patient with SVT and **hypotension** (hemodynamic instability), calcium channel blockers like Verapamil are **contraindicated**. Verapamil has potent negative inotropic and vasodilator properties. Administering it to a hypotensive patient can cause a further drop in systemic vascular resistance and myocardial contractility, potentially leading to cardiovascular collapse or cardiac arrest. **2. Analysis of Other Options:** * **Direct Current (DC) Cardioversion (Option C):** This is the **treatment of choice** for any tachyarrhythmia causing hemodynamic instability (hypotension, altered mentation, or pulmonary edema) under general anesthesia. Synchronized cardioversion (starting at 50-100J) provides immediate rhythm correction. * **Adenosine (Option B):** If the patient is unstable but IV access is immediately available, Adenosine (6mg, then 12mg) can be attempted as it has an ultra-short half-life and may terminate the reentry circuit without prolonged hemodynamic depression. * **Carotid Sinus Massage (Option A):** This is a non-invasive vagal maneuver that can be attempted quickly to increase vagal tone and slow AV node conduction while preparing for cardioversion. **Clinical Pearls for NEET-PG:** * **Unstable Tachycardia:** Always choose **Synchronized DC Cardioversion**. * **Stable SVT:** First-line is Vagal maneuvers, followed by Adenosine (Drug of Choice). * **Verapamil Warning:** Never give Verapamil in wide-complex tachycardias of unknown origin or in patients with WPW syndrome + Atrial Fibrillation, as it can lead to ventricular fibrillation. * **Amiodarone:** Preferred for stable ventricular tachycardia or refractory SVT.

Question 2: What is the component of Advanced Cardiovascular Life Support (ACLS) in accordance with AHA 2015 guidelines?

A. Chest compression 100-150 per minute
B. Chest compression at least 5 cm/2 inch (Correct Answer)
C. Vasopressors are used to maintain MAP > 70 mmHg in non-responsive to fluids
D. 1 Breath every 8 seconds

Explanation: This question tests knowledge of the **AHA 2015 Guidelines for CPR and Emergency Cardiovascular Care**, which emphasize high-quality chest compressions as the cornerstone of ACLS. ### **Explanation of the Correct Answer** **Option B** is correct. According to the 2015 guidelines, for an average adult, the chest should be compressed to a depth of **at least 2 inches (5 cm)** but should not exceed 2.4 inches (6 cm). Adequate depth is critical to create enough intrathoracic pressure and direct cardiac compression to maintain vital organ perfusion during cardiac arrest. ### **Analysis of Incorrect Options** * **Option A:** The recommended compression rate is **100–120 per minute**. A rate exceeding 150/min is incorrect as it prevents adequate ventricular filling and reduces cardiac output. * **Option C:** While vasopressors (like Epinephrine) are used in ACLS, the primary goal during active resuscitation is achieving **ROSC** (Return of Spontaneous Circulation), not titrating to a specific MAP of 70 mmHg. MAP targets are more relevant in post-cardiac arrest care. * **Option D:** Once an advanced airway is in place, the ventilation rate is **1 breath every 6 seconds** (10 breaths per minute). A rate of 1 breath every 8 seconds is too slow. ### **High-Yield Clinical Pearls for NEET-PG** * **Compression-to-Ventilation Ratio:** 30:2 (for all adults) until an advanced airway is placed. * **Chest Recoil:** Allow complete chest recoil after each compression; do not "lean" on the chest. * **Minimize Interruptions:** Limit pauses in compressions to less than 10 seconds. * **Capnography (ETCO2):** If ETCO2 is **<10 mmHg**, it indicates poor quality CPR; aim for >20 mmHg. * **Defibrillation:** For shockable rhythms (VF/pVT), the initial dose for a biphasic defibrillator is typically **120–200 J**.

Question 3: What is the most common complication of cardiac catheterization?

A. Arrhythmia
B. Hypertension
C. Vascular bleeding (Correct Answer)
D. Contrast reaction

Explanation: **Explanation:** Cardiac catheterization is a common invasive procedure used for both diagnostic and interventional purposes. The correct answer is **Vascular bleeding**, which remains the most frequent complication associated with this procedure. **1. Why Vascular Bleeding is Correct:** The procedure requires percutaneous arterial access (most commonly the radial or femoral artery) using large-bore sheaths. Vascular complications, specifically **local site bleeding and hematoma formation**, occur in approximately 1.5% to 5% of cases. This is driven by the use of systemic anticoagulation (heparin) during the procedure, the size of the catheters, and the challenges of achieving adequate hemostasis at the puncture site post-procedure. **2. Analysis of Incorrect Options:** * **Arrhythmias:** While common *during* the procedure (especially ventricular ectopy when the catheter touches the endocardium), they are usually transient and self-limiting, making them less frequent as a lasting complication compared to bleeding. * **Hypertension:** This is generally a physiological response to pain or anxiety rather than a direct complication of the catheterization itself. * **Contrast Reaction:** While serious (ranging from mild rashes to anaphylaxis or contrast-induced nephropathy), the incidence is significantly lower than vascular access site complications due to the modern use of non-ionic, low-osmolar contrast media. **Clinical Pearls for NEET-PG:** * **Radial vs. Femoral:** The shift from femoral to **radial artery access** has significantly reduced the incidence of major vascular bleeding and is now the preferred approach. * **Most Common Cause of Death:** While bleeding is the most common complication, the most common cause of *mortality* during cardiac cath is usually related to the underlying cardiac pathology (e.g., myocardial infarction or perforation). * **Retroperitoneal Hematoma:** Always suspect this in a patient with sudden hypotension and back pain following femoral access.

Question 4: A 62-year-old man is suffering from arrhythmias post triple coronary bypass surgery. Potassium has been administered, and his urine output is 20 to 30 mL/h. The serum potassium level is 6.2 mEq/L. Which of the following medications counteracts the cardiac effects of hyperkalemia without reducing the serum potassium level?

A. Sodium polystyrene sulfonate
B. Sodium bicarbonate
C. 50% dextrose with insulin
D. Calcium gluconate (Correct Answer)

Explanation: ### Explanation The correct answer is **Calcium gluconate**. **Mechanism of Action (Why it is correct):** Hyperkalemia (K⁺ > 5.5 mEq/L) increases the resting membrane potential of cardiac myocytes, bringing it closer to the threshold potential. This leads to membrane hyperexcitability followed by inactivation of sodium channels, causing bradycardia, heart block, or ventricular fibrillation. **Calcium gluconate** (or Calcium chloride) acts as a **membrane stabilizer**. It antagonizes the cardiotoxic effects of potassium by increasing the threshold potential, thereby restoring the normal gradient between resting and threshold potentials. Crucially, calcium **does not lower** the serum potassium level; it only protects the heart. **Analysis of Incorrect Options:** * **Sodium polystyrene sulfonate (Kayexalate):** This is a cation-exchange resin that removes potassium from the body via the GI tract. It lowers the total body potassium level. * **Sodium bicarbonate:** This promotes an intracellular shift of potassium ions in exchange for hydrogen ions (alkalosis-induced shift), thereby reducing serum potassium levels. * **50% Dextrose with Insulin:** Insulin stimulates the Na⁺-K⁺ ATPase pump, shifting potassium from the extracellular to the intracellular compartment. This reduces serum potassium levels. **High-Yield Clinical Pearls for NEET-PG:** * **First-line treatment:** In hyperkalemia with ECG changes (e.g., peaked T waves, widened QRS), Calcium gluconate is the **immediate first step**. * **Duration:** The effect of Calcium gluconate is rapid (1–3 minutes) but short-lived (30–60 minutes). * **Caution:** Use calcium with extreme caution in patients taking **Digoxin**, as it can potentiate digoxin toxicity ("stone heart"). * **Calcium Gluconate vs. Chloride:** Calcium chloride contains 3x more elemental calcium than gluconate but is more irritating to peripheral veins.

Question 5: What is the concentration of adrenaline used in CPR?

A. 1:10,00,000
B. 1:1,00,000
C. 1:10,000
D. 0.736111111 (Correct Answer)

Explanation: **Explanation:** The standard concentration of Adrenaline (Epinephrine) used during **Cardiopulmonary Resuscitation (CPR)** for intravenous/intraosseous administration is **1:10,000**. This corresponds to **0.1 mg/mL**. In a standard 10 mL pre-filled syringe, this provides the recommended dose of 1 mg. **Analysis of Options:** * **Option C (1:10,000):** This is the standard "cardiac" concentration. It is used in ACLS protocols to improve coronary and cerebral perfusion pressure via alpha-1 mediated vasoconstriction. * **Option D (0.736111111):** While marked as correct in the prompt, this numerical value appears to be a **typographical error** or a technical glitch in the question database. In medical practice and standard NEET-PG curriculum, the correct answer is **1:10,000**. If this value appeared in an exam, it would likely be a disputed or "bonus" question. * **Option B (1:1,00,000):** This concentration (10 mcg/mL) is typically used as a local vasoconstrictor (e.g., with local anesthetics) or as a titration bolus for treating intraoperative hypotension, but not for pulseless arrest. * **Option A (1:10,00,000):** This is a very dilute concentration sometimes used in specialized pediatric infusions or specific local infiltration techniques. **High-Yield Clinical Pearls for NEET-PG:** 1. **Dose in CPR:** 1 mg IV/IO every 3–5 minutes. 2. **Endotracheal Dose:** If IV access is unavailable, the dose is 2–2.5 times the IV dose (2–2.5 mg), diluted in 5–10 mL of saline. 3. **Anaphylaxis:** The preferred concentration for Intramuscular (IM) injection is **1:1,000** (1 mg/mL). 4. **Mechanism:** Adrenaline acts on $\alpha_1$, $\beta_1$, and $\beta_2$ receptors. In CPR, its $\alpha_1$ effects are most critical for increasing systemic vascular resistance.

Question 6: Which of the following is the best inotropic drug for use in right heart failure?

A. Dobutamine
B. Dopamine
C. Digoxin
D. Milrinone (Correct Answer)

Explanation: **Explanation:** The management of right heart failure (RHF) requires a drug that simultaneously increases myocardial contractility (inotropy) and reduces the afterload on the right ventricle by decreasing pulmonary vascular resistance (PVR). **Why Milrinone is the Correct Answer:** Milrinone is a **Phosphodiesterase-3 (PDE3) inhibitor**. It works by increasing intracellular cAMP in cardiac and smooth muscle cells. This leads to two synergistic effects: 1. **Inotropy:** Increases cardiac contractility. 2. **Inodilatation:** Causes potent systemic and, more importantly, **pulmonary vasodilation**. By reducing pulmonary artery pressure, Milrinone decreases the workload of the thin-walled right ventricle, making it the "gold standard" inotropic agent for RHF and pulmonary hypertension. **Analysis of Incorrect Options:** * **Dobutamine (Option A):** While an excellent inotrope ($\beta_1$ agonist), it has less predictable effects on pulmonary vascular resistance compared to Milrinone and can increase myocardial oxygen demand significantly. * **Dopamine (Option B):** At higher doses, it causes $\alpha_1$-mediated vasoconstriction, which can increase pulmonary artery pressures and worsen the strain on the right ventricle. * **Digoxin (Option C):** It has a slow onset of action and weak inotropic effects; it is not used for the acute management of right heart failure. **High-Yield Clinical Pearls for NEET-PG:** * **Milrinone Side Effect:** The most common side effect is **hypotension** due to systemic vasodilation; it may require a concurrent vasopressor (like Noradrenaline). * **Renal Clearance:** Milrinone is renally excreted; doses must be adjusted in patients with renal impairment. * **Inodilator Concept:** Remember that Milrinone and Levosimendan are classified as "inodilators." * **Right Ventricle (RV):** Unlike the left ventricle, the RV is highly sensitive to afterload; therefore, reducing PVR is the cornerstone of RHF therapy.

Question 7: What is the anesthetic agent of choice in congenital heart disease with a right-to-left shunt?

A. Thiopentone
B. Propofol
C. Etomidate
D. Ketamine (Correct Answer)

Explanation: **Explanation:** In congenital heart disease (CHD) with a **right-to-left (R-L) shunt** (e.g., Tetralogy of Fallot), the primary anesthetic goal is to maintain or increase **Systemic Vascular Resistance (SVR)** while avoiding increases in Pulmonary Vascular Resistance (PVR). A drop in SVR worsens the shunt, leading to increased cyanosis and "Tet spells." **Why Ketamine is the Correct Answer:** Ketamine is a sympathomimetic agent that increases SVR by stimulating the release of endogenous catecholamines. By increasing systemic pressure relative to pulmonary pressure, Ketamine effectively **decreases the R-L shunt fraction**, thereby improving arterial oxygenation. It also maintains heart rate and contractility, making it the safest induction agent for cyanotic heart disease. **Why the Other Options are Incorrect:** * **Propofol & Thiopentone:** Both agents are potent vasodilators that significantly **decrease SVR**. This drop in systemic pressure allows more blood to bypass the lungs via the shunt, leading to profound hypoxia and cardiovascular collapse in R-L shunt patients. * **Etomidate:** While cardiostable, Etomidate typically causes a mild decrease or no change in SVR. It does not provide the beneficial increase in SVR seen with Ketamine, making it a secondary choice. **High-Yield Clinical Pearls for NEET-PG:** * **Induction Speed:** In R-L shunts, **intravenous induction is faster** (bypass of lungs), while **inhalation induction is slower** (decreased pulmonary blood flow). * **The "Tet Spell" Management:** Treatment includes 100% $O_2$, knee-chest position (to increase SVR), and drugs like **Phenylephrine** (pure alpha-agonist to increase SVR) or **Morphine** (to calm the patient and reduce infundibular spasm). * **Avoid:** Dehydration, crying/struggling (increases PVR), and histamine-releasing drugs.

Question 8: A 71-year-old man returns from the operating room after undergoing a triple coronary bypass. His initial cardiac index is 2.8 L/(minm2). His heart rate is then noted to be 55 beats per minute, BP is 110/80 mm Hg, wedge pressure is 15, and his cardiac index has dropped to 1.6 L/(minm2). He has a normal left ventricle. Which of the following maneuvers will increase his cardiac output?

A. Increase his peripheral vascular resistance.
B. Increase his central venous pressure.
C. Increase his heart rate to 90 by electrical pacing. (Correct Answer)
D. Increase his blood viscosity.

Explanation: ### Explanation **1. Why Option C is Correct:** The core concept here is the formula for Cardiac Output (CO): **CO = Stroke Volume (SV) × Heart Rate (HR)**. In the post-coronary artery bypass graft (CABG) period, the myocardium often exhibits decreased compliance (stiffness) due to stunning or surgical manipulation. In a patient with a normal left ventricle but a low heart rate (55 bpm) and a significantly dropped Cardiac Index (1.6 L/min/m²), the stroke volume is likely limited by this reduced compliance. Since the wedge pressure (15 mmHg) is already at the upper limit of normal, further volume (SV) cannot be easily increased. Therefore, the most effective way to increase CO is to increase the heart rate. Electrical pacing to 90 bpm directly increases the "HR" component of the equation, thereby restoring the Cardiac Index. **2. Why Other Options are Incorrect:** * **Option A (Increase PVR):** Increasing peripheral vascular resistance increases afterload. This makes it harder for the heart to pump blood, which would further decrease the stroke volume and cardiac output. * **Option B (Increase CVP):** The wedge pressure is already 15 mmHg, indicating adequate preload. Adding more volume to increase CVP in a non-compliant heart may lead to pulmonary edema without significantly improving stroke volume (Frank-Starling plateau). * **Option D (Increase Viscosity):** Increased blood viscosity increases resistance to flow (Poiseuille's Law), increasing the workload of the heart and decreasing output. **3. Clinical Pearls for NEET-PG:** * **Post-CABG Bradycardia:** Common due to hypothermia, medications (Beta-blockers), or surgical trauma to the conduction system. * **Optimal HR:** In the immediate post-op period, a heart rate of 80–100 bpm is often targeted to maintain CO. * **Fixed Stroke Volume:** In patients with "stiff" hearts (restrictive physiology or post-op stunning), cardiac output becomes **heart rate-dependent**.

Question 9: What is the drug of choice for intraoperative right heart failure due to pulmonary hypertension?

A. Dopamine
B. Isoprenaline
C. Milrinone (Correct Answer)
D. Halothane

Explanation: **Explanation:** The management of intraoperative right heart failure (RHF) secondary to pulmonary hypertension focuses on two goals: **reducing pulmonary vascular resistance (PVR)** to unload the right ventricle and **increasing myocardial contractility** (inotropy). **Why Milrinone is the Correct Answer:** Milrinone is a **Phosphodiesterase-3 (PDE3) inhibitor**. It increases intracellular cAMP in both cardiac muscle and vascular smooth muscle. This results in a dual action known as **"Inodilatation"**: 1. **Inotropy:** It increases right ventricular (RV) contractility without significantly increasing myocardial oxygen demand. 2. **Vasodilation:** It causes potent pulmonary vasodilation, thereby decreasing RV afterload. Unlike catecholamines, its effects are independent of beta-receptors, making it effective even in patients with receptor down-regulation or those on beta-blockers. **Analysis of Incorrect Options:** * **A. Dopamine:** At higher doses, dopamine causes alpha-1 mediated vasoconstriction, which can increase pulmonary artery pressure and worsen RV afterload. * **B. Isoprenaline:** While it is a potent inotrope and pulmonary vasodilator, it causes significant tachycardia and systemic hypotension, which can compromise RV coronary perfusion. * **D. Halothane:** This is a potent myocardial depressant and can worsen heart failure; it also lacks specific pulmonary vasodilatory properties. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard:** Inhaled Nitric Oxide (iNO) is the most specific pulmonary vasodilator as it does not cause systemic hypotension, but among systemic drugs, **Milrinone** is the drug of choice. * **The "Vicious Cycle":** In RHF, systemic hypotension must be avoided because the RV depends heavily on the pressure gradient between the aorta and the right ventricle for its coronary perfusion. * **Inodilator Concept:** Milrinone and Levosimendan are the two primary inodilators tested in exams.

Question 10: What is the recommended concentration of adrenaline for ACLS/Cardiac Arrest Resuscitation?

A. 1 : 10 lakhs
B. 1 : 1 lakh
C. 0.736111111
D. 1 : 10000 (Correct Answer)

Explanation: ### Explanation **Correct Option: D (1 : 10,000)** In the setting of Cardiac Arrest (ACLS), the standard dose of Adrenaline (Epinephrine) is **1 mg administered intravenously or intraosseously every 3–5 minutes**. To deliver this dose safely and accurately, a concentration of **1 : 10,000** is used. * **Calculation:** 1 : 10,000 means 1 gram in 10,000 mL, which equals **0.1 mg/mL**. * Therefore, a standard 10 mL pre-filled syringe of 1 : 10,000 contains exactly 1 mg of adrenaline. This dilute concentration is preferred during resuscitation to ensure rapid systemic distribution and to minimize the risk of tissue necrosis compared to more concentrated forms. **Analysis of Incorrect Options:** * **Option A (1 : 10 lakhs):** This is an extremely dilute concentration (1 mcg/mL) sometimes used in local infiltration to minimize bleeding (e.g., in plastic surgery), but it is insufficient for cardiac resuscitation. * **Option B (1 : 1 lakh):** This concentration (10 mcg/mL) is commonly used as an additive to local anesthetics (like Lignocaine) to prolong the duration of action and provide local vasoconstriction. * **Option C (0.736111111):** This is a distractor value with no clinical relevance in pharmacology or anesthesia. **High-Yield Clinical Pearls for NEET-PG:** 1. **Routes of Adrenaline:** * **IV/IO:** 1 mg of 1 : 10,000. * **Intramuscular (Anaphylaxis):** 0.5 mg of **1 : 1,000** (0.5 mL). * **Endotracheal:** 2–2.5 mg (2–2.5 times the IV dose) diluted in 5–10 mL saline. 2. **Mechanism in ACLS:** Adrenaline’s **$\alpha$-1 effects** cause peripheral vasoconstriction, which increases coronary and cerebral perfusion pressure during CPR. 3. **Shockable vs. Non-shockable:** In VF/pVT, give adrenaline after the 2nd shock; in PEA/Asystole, give it as soon as possible.

Practice by Chapter

Cardiovascular Physiology

Practice Questions

Anesthesia for Coronary Artery Disease

Practice Questions

Valvular Heart Disease Management

Practice Questions

Congenital Heart Disease in Adults

Practice Questions

Cardiopulmonary Bypass Principles

Practice Questions

Myocardial Protection Strategies

Practice Questions

Inotropes and Vasopressors

Practice Questions

Vasodilators in Cardiac Anesthesia

Practice Questions

Transesophageal Echocardiography

Practice Questions

Off-Pump Cardiac Surgery

Practice Questions

Management of Cardiac Pacemakers and ICDs

Practice Questions

Fast-Track Cardiac Anesthesia

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free